Comment on: Bone Marrow Mesenchymal Stem Cells for Heart Failure Treatment: A Systematic Review and Meta-Analysis - 03/10/23
Doi : 10.1016/j.hlc.2023.06.572
Qian Sun, BPharm, Qiuhan Li, BPharm 1, Jundong Gu, MD, PhD ⁎ 
National Engineering Research Center of Cell Products, Tianjin AmCellGene Engineering Co. Ltd, Tianjin, China
∗Corresponding author at: Jundong Gu, MD, PhD, National Engineering Research Center of Cell Products, Tianjin AmCellGene Engineering Co. Ltd, Tianjin 300457, PR ChinaNational Engineering Research Center of Cell ProductsTianjin AmCellGene Engineering Co. LtdTianjin300457PR China
Keywords : Bone marrow mesenchymal stem cells, Commentary
Il testo completo di questo articolo è disponibile in PDF.
© 2023
Pubblicato da Elsevier Masson SAS.
Vol 32 - N° 9
P. e57-e58 - settembre 2023 Ritorno al numero
Articolo precedente
- Association of Hospital Volume and Outcomes Following Off-Pump Coronary Artery Bypass Grafting
- Nikhil Chervu, Arjun Verma, Sara Sakowitz, Syed Shahyan Bakhtiyar, Joseph Hadaya, Yas Sanaiha, Peyman Benharash
- Response to Letter to the Editor: Comment on Bone Marrow Mesenchymal Stem Cells for Heart Failure Treatment: A Systematic Review and Meta-Analysis
- Abdullah Murhaf Al-Khani, Yazan Kalou, Khawaja Husnain Haider
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?